News

Recruitment has now closed for Clinical Trial in Australia
By MND Australia
September 5, 2011

for the Phase 3 Study of Dexpramipexole in ALS/MND. Inclusion criteria was very strict and numbers of people enrolled in Australia are small. This trial, however, is very significant for Australia as it is the first time Australians living with MND have been included in an international multi site clinical trial.

Click here for details of the trial and information about which sites are involved.

 
Many documents available for download on this website are pdf files - if you need to download ADOBE Reader to open these documents please click on the icon
 
Search
 
Bookmark and Share